ES8504710A1 - Procedimiento para la resolucion optica de una mezcla de enantiomeros de un derivados de piperidina. - Google Patents

Procedimiento para la resolucion optica de una mezcla de enantiomeros de un derivados de piperidina.

Info

Publication number
ES8504710A1
ES8504710A1 ES530355A ES530355A ES8504710A1 ES 8504710 A1 ES8504710 A1 ES 8504710A1 ES 530355 A ES530355 A ES 530355A ES 530355 A ES530355 A ES 530355A ES 8504710 A1 ES8504710 A1 ES 8504710A1
Authority
ES
Spain
Prior art keywords
methyl
phenylpiperidine
methoxyphenoxy
enantiomers
trans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES530355A
Other languages
English (en)
Spanish (es)
Other versions
ES530355A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrosan ApS
Original Assignee
Ferrosan ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan ApS filed Critical Ferrosan ApS
Publication of ES530355A0 publication Critical patent/ES530355A0/es
Publication of ES8504710A1 publication Critical patent/ES8504710A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES530355A 1983-03-07 1984-03-07 Procedimiento para la resolucion optica de una mezcla de enantiomeros de un derivados de piperidina. Expired ES8504710A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK111583A DK149624C (da) 1983-03-07 1983-03-07 Fremgangsmaade til fremstilling af (+)-trans-3-((4-methoxyphenoxy)-methyl)-1-methyl-4-phenylpiperidin eller et farmaceutisk acceptabelt salt heraf ud fra en blanding af enantiomererne

Publications (2)

Publication Number Publication Date
ES530355A0 ES530355A0 (es) 1985-05-01
ES8504710A1 true ES8504710A1 (es) 1985-05-01

Family

ID=8101175

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530355A Expired ES8504710A1 (es) 1983-03-07 1984-03-07 Procedimiento para la resolucion optica de una mezcla de enantiomeros de un derivados de piperidina.

Country Status (12)

Country Link
US (1) US4571424A (OSRAM)
EP (1) EP0123832B1 (OSRAM)
JP (1) JPS6069065A (OSRAM)
AT (1) ATE30910T1 (OSRAM)
CA (1) CA1257599A (OSRAM)
DE (1) DE3467574D1 (OSRAM)
DK (1) DK149624C (OSRAM)
ES (1) ES8504710A1 (OSRAM)
FI (1) FI80261C (OSRAM)
GR (1) GR81929B (OSRAM)
IE (1) IE57002B1 (OSRAM)
NO (1) NO164594C (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5254556A (en) * 1988-11-07 1993-10-19 Janssen Pharmaceutica N.V. 3-piperidinyl-1,2-benzisoxazoles
IL98757A (en) * 1990-07-18 1997-01-10 Novo Nordisk As Piperidine derivatives their preparation and pharmaceutical compositions containing them
DE69404306T2 (de) * 1993-05-28 1997-10-30 Pfizer Verfahren zur herstellung und optischen auflösung von 2-phenyl-3-aminopiperidine
US7470244B2 (en) * 1996-01-26 2008-12-30 Harrison Jr Shelton E Flexion-discouraging splint system, method and device
JP2007505097A (ja) 2003-09-12 2007-03-08 ファイザー・インク アルファ−２−デルタリガンドとセロトニン／ノルアドレナリン再取込み阻害薬を含む組合せ
DE102005063192A1 (de) * 2005-12-30 2007-07-05 Basf Ag Racematspaltung von 2,6-trans-Dimethyl-morpholin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4442113A (en) * 1981-05-07 1984-04-10 A/S Ferrosan Long-term weight reduction of obese patients using femoxetine

Also Published As

Publication number Publication date
ES530355A0 (es) 1985-05-01
NO164594B (no) 1990-07-16
NO164594C (no) 1990-10-24
DK111583A (da) 1984-09-08
JPS6069065A (ja) 1985-04-19
DK111583D0 (da) 1983-03-07
US4571424A (en) 1986-02-18
EP0123832A1 (en) 1984-11-07
CA1257599A (en) 1989-07-18
IE840496L (en) 1984-09-07
GR81929B (OSRAM) 1984-12-12
DK149624B (da) 1986-08-18
EP0123832B1 (en) 1987-11-19
NO840847L (no) 1984-09-10
FI840872A0 (fi) 1984-03-05
CA1265522C (OSRAM) 1990-02-06
IE57002B1 (en) 1992-03-11
FI80261B (fi) 1990-01-31
FI840872L (fi) 1984-09-08
DK149624C (da) 1987-02-02
ATE30910T1 (de) 1987-12-15
FI80261C (fi) 1990-05-10
DE3467574D1 (en) 1987-12-23

Similar Documents

Publication Publication Date Title
HUT59376A (en) Process for producing r(+)-n-propargyl-1-aminoindane and pharmaceutical compositions comprising such compound
ZA876562B (en) Optically active compounds
FR2623498B1 (fr) Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques
AU636351B2 (en) N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
ES8504710A1 (es) Procedimiento para la resolucion optica de una mezcla de enantiomeros de un derivados de piperidina.
HU901832D0 (en) Process for producing eseroline-carbaminates and pharmaceutical preparatives containing such compounds
NO171905C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive eicosatriynsyre-5,8,11-forbindelser
PL300747A1 (en) Method of obtaining substantially pure clavulanic acid
RO92320B (ro) Procedeu pentru prepararea clorurii de carnitinnitril optic activ
EP0508133A3 (en) Method of preparation of l-carnitine from d,l-carnitine nitrile salts
GEP19970819B (en) Method of producing racemates of complex ethers of cis-and/or trans-apotartronic acid isomers thereof,possessing optical activity
JPS5679663A (en) Manufacture of enantiomer form of 44cyann11 *nnmethyllnn*2***3***4***dimethoxyphenyl**ethyl** amino**55methyll44*3**4**5**trimethoxyphenyl** hexane and its salt
AU6262990A (en) Process for the chemical resolution of 5-alkoxy-substituted (+ or -)-1,3-dimethyloxindolylethylamines
YU60778A (en) Process for the enzymatic hydrolysis of racemic hydantoin into optically active amino-acids
KR940003937A (ko) 신규한 이소부틸-치환 메탄술포닐 퀴놀릴메톡시페닐-시클로알킬아세트아미드
ES2003994A6 (es) Procedimiento de preparacion de nuevas 2-cloro-12-(3-dimetilamino-2-metilpropil)-12h-dibenzo(d,g) (i,3,6) dioxazocinas opticamente activas y de sus sales de adicion acidas farmaceuticamente aceptables
EP0204481A3 (en) Process for optically active threo-3-(3,4-methylenedioxyphenyl) serine
GR3008318T3 (OSRAM)
IE882357L (en) Benzoxazine derivatives
FR2375229A1 (fr) Enantiomeres levogyres d'acides ()-(3-alkyl-4-oxo-5-n-piperidino-thiazolidines-2-ylidene) acetiques et leur application pharmacologique
FR2442847A1 (fr) Procede de preparation d'hydroxyimino-eburnanes
FR2372842A1 (fr) Procede pour la preparation d'esters de la 2,2'-anhydro-1b-d-arabinofuranosyl-5-fluorocytosine
JPS5412383A (en) Method of racemizing 2-(p-methoxybenzyl)-1,3,4-trimethyl-1,2,5,6,- thtrahydropyridine
JPS56135447A (en) Optical resolving method of alpha-phenyl-beta- p-tolyl ethylamine
KR890002071A (ko) 테트라하이드로 벤조티아졸, 그의 제조방법 및 용도

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991108